Choice Health at Home Ends January with Two Deal Announcements
Choice Health at Home ended the month with two deal announcements, both transactions reported on January 30, 2026. The first announcement was the acquisition of Cy-Fair Health Care and Alliant Home Health, Palliative, and Hospice Care. Cy-Fair Health Care is located in Tomball, Texas, and provides home health services throughout Southeast Texas. Alliant Home Health, Palliative, and Hospice Care provides both home health and hospice services. The organization operates two offices in Colorado, one in Westminster and one in Colorado Springs. Patients, families and referral partners can expect continuity of care throughout the transition. Existing staff will remain in place, and services will... Read More »
Morris & Dickson Completes Prodigy Health Deal
On Monday, January 26, Morris & Dickson announced the successful completion of the acquisition of Prodigy Health. Effective immediately, Prodigy Health employees will become part of the Morris & Dickson family. Financial terms of the deal were not disclosed. Established in 2001 in Austin, Texas, Prodigy Health is a specialty pharmaceutical distribution and services company. Founded in 1841 and headquartered in Shreveport, Louisiana, Morris & Dickson is an independent full-line and specialty pharmaceutical distributor serving health systems, independent pharmacies, clinics, infusion centers and alternative care facilities nationwide. The company combines next-day delivery,... Read More »
Most Active Buyers in the Home Health & Hospice Sector
The Home Health & Hospice (HH&H) sector saw steady M&A momentum in 2025, with 110 transactions announced according to LevinPro HC data. This marked a solid increase from the 97 deals in 2024 and 99 in 2023, reflecting continued consolidation amid an aging population, rising demand for in-home care and strategic efforts by providers to expand geographic reach and service capabilities. Activity remained focused on smaller, tuck-in acquisitions, though the year also featured the closing of Optum’s $3.3 billion acquisition of Amedisys in August. That deal followed a lengthy regulatory review and settlement with the Department of Justice, and it significantly reshaped... Read More »
Agenda Health Named Top Advisor in Home Health & Hospice for 2025
The Home Health and Hospice (HH&H) M&A market regained momentum in 2025 as buyers returned to smaller, strategic acquisitions amid ongoing reimbursement pressure and operator fragmentation. According to LevinPro HC data, 110 HH&H transactions were announced during the year, marking an increase from the 97 deals in 2024 and 99 in 2023, and signaling renewed confidence in home-based care platforms despite a still-challenging operating environment. Agenda Health, an Austin, Texas-based M&A advisory firm specializing in healthcare, emerged as the most active advisor in the HH&H sector in 2025, according to data from LevinPro HC. The firm advised on nine completed HH&H... Read More »
